The CYP2U1 gene helps the body break down certain fats, especially in nerve tissue, which supports healthy movement and vision. If this gene does not work properly, nerve cells may be affected over time, which can lead to stiffness and weakness in the legs, walking or balance problems, and sometimes learning or vision changes. People with two nonworking copies of the CYP2U1 gene can develop a hereditary condition called spastic paraplegia type 56.
What is a gene?
A gene is a stretch of DNA that carries instructions your cells use to make molecules or regulate processes in the body. Some genes provide the directions for producing proteins, the parts of cells that do the work. Other genes mainly control when certain processes happen, where they occur, and how strongly they are carried out. Together, genes shape how the body develops and functions, and they can influence how you respond to food, stress, or medications. To explore this topic further, you can learn more in the LearnHub.
Overview
CYP2U1Gene function
What if the gene works
The CYP2U1 gene helps make an enzyme that processes certain fats, including fatty acids, in the brain and other tissues. This supports normal cell function, especially in nerve cells.
Risk
What if the gene does not work
Variants in the CYP2U1 gene are linked to hereditary spastic paraplegia, often causing increasing leg stiffness and weakness, sometimes with learning or vision problems. Milder and more severe variants can influence when symptoms begin and how wide the feature range is.
Treatment
What does that mean for your treatment
No CYP2U1-specific treatment or management approach is currently established; care for people with pathogenic variants in the CYP2U1 gene is based on symptom management rather than a gene-directed drug.
Conditions associated with CYP2U1
Gene function
What if the gene works
Your cells use the CYP2U1 gene to process certain fats that help tissues work smoothly, especially in the brain and nerves. It makes an enzyme that adds oxygen to long chain fatty acids, which changes how those fats are used or broken down. Understanding what the CYP2U1 gene does helps explain how cells manage everyday fat handling and signaling.
The CYP2U1 gene helps your cells modify long chain fatty acids by adding oxygen to them. This step can change how these fats are stored, used, or cleared.
Some fats processed by the CYP2U1 gene also act as chemical signals between cells. By adjusting these fats, the gene helps keep signaling more balanced and controlled.
CYP2U1 activity is especially relevant in tissues such as the brain, where fat handling is part of normal cell function. This supports the steady upkeep of nerve cell membranes and related cell tasks.
What is a variant?
A genetic variant is a minor change in the DNA sequence of a gene. These changes are common and form part of normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. Sometimes, however, a variant can more significantly change how a gene functions and may contribute to, or cause, a genetic condition.
Genetic variants
What if the gene does not work
Many the CYP2U1 gene variants change the enzyme’s shape, stability, or activity, so cells make too little working protein or none at all. In plain terms, how CYP2U1 gene variants affect protein function often comes down to reduced fatty acid processing and stressed mitochondria, the parts of cells that help manage energy. Some variants leave partial activity, while more severe variants can nearly abolish it. That difference may influence how early and how strongly features linked to the CYP2U1 gene appear.
How variants are linked to conditions
Pathogenic variants in the CYP2U1 gene cause spastic paraplegia type 56, an inherited neurologic condition that often leads to gradually increasing leg stiffness, weakness, and walking problems. In CYP2U1 gene-related spastic paraplegia type 56, some people also develop vision loss from optic nerve involvement, learning difficulties, or unusual movements. The exact features and age at onset can vary from person to person.
A variant is not necessarily a diagnosis
Variants in genes are a normal part of human biology and are widely seen in the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when several genes and environmental factors play a role. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For CYP2U1, risk is mostly tied to inheritance: the condition is usually linked to harmful changes in both copies of the CYP2U1 gene, so family history and whether both parents carry a change matter most. There is not yet broadly confirmed evidence that specific lifestyle or environmental factors meaningfully change the chance of developing this CYP2U1-related condition.
Inheritance of CYP2U1 variants
CYP2U1-related conditions are inherited in an autosomal recessive pattern. This means a person usually inherits one CYP2U1 gene variant from each parent, and both parents are typically healthy carriers. When both parents carry a variant, each pregnancy has a 25% chance of resulting in a child with the condition, a 50% chance of producing a carrier child, and a 25% chance of producing a child without the familial variant. In practical terms, CYP2U1 gene inheritance often becomes relevant when a condition appears in siblings even though the parents have no symptoms.
What does my CYP2U1 result mean for my family?
For families of someone with a CYP2U1-related condition, the usual pattern is recessive, which means close relatives may also carry the changed gene even if they do not have symptoms. Brothers and sisters could be affected or could be carriers, and other blood relatives may also be carriers. This can matter for family planning, especially if both parents carry a CYP2U1 change.
Genetic information
Genetic testing
How you find out about variants
CYP2U1 genetic testing looks for variants by reading the DNA sequence from a blood sample or saliva swab. It is often included in a broader inherited nerve condition panel or an exome test, which checks many genes at once. Results may find a disease-causing variant, no relevant change, or a variant of uncertain significance.
When should I consider getting a genetic test?
Testing for CYP2U1 may be considered if someone has unexplained leg stiffness and weakness that slowly worsen, often starting in childhood, especially with balance, learning, or vision problems. It can also help when there is a family history of a similar inherited nerve condition.
A genetic result is only one part of your health story
Genetic results can provide useful insight, but how much they reveal depends on the condition and on the specific type of variant involved. Over time, many factors influence how the body works, including lifestyle, environment, age, and medical history. For some conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas such as response to medication, genetic results can also help put personal experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small inherited differences can change how the body breaks down a drug, moves it through the body, or responds to it at its target, so the same treatment may work better for one person than for another. These differences are common and can influence how much benefit someone gets from a medicine or how sensitive they are to side effects.
What is Pharmacogenetics?
Pharmacogenetics is the area of study that examines how genetic differences affect the way people respond to medications. It looks at links between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes influence how strongly a drug works or how the body processes it. This information can support treatment decisions that are more informed and more personalized. More detail on this topic is available in the LearnHub.
Drugs influenced by the CYP2U1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how medicines work, so questions about side effects, new symptoms, or whether a treatment is right for you are best discussed with your doctor.
History
CYP2U1 entered the medical literature in the early 2000s, when researchers identified it as a previously unrecognized member of the cytochrome P450 gene family. From these first observations, research expanded steadily. A major step came later when variants in the CYP2U1 gene were linked to hereditary spastic paraplegia type 56, helping explain some families’ long-standing pattern of walking difficulties and related nerve symptoms. As more people were studied, clinicians recognized that the condition could vary from one person to another, even within the same family. Over time, descriptions became more precise, and CYP2U1 became part of the broader history of genes connected to inherited neurologic conditions.